Pulmonx Corporation Return on Tangible Equity 2019-2024 | LUNG
Current and historical return on tangible equity values for Pulmonx Corporation (LUNG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Pulmonx Corporation Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.06B | $0.09B | -54.94% |
| 2024-06-30 | $-0.06B | $0.10B | -52.02% |
| 2024-03-31 | $-0.06B | $0.11B | -49.27% |
| 2023-12-31 | $-0.06B | $0.12B | -47.66% |
| 2023-09-30 | $-0.06B | $0.12B | -44.53% |
| 2023-06-30 | $-0.06B | $0.13B | -40.96% |
| 2023-03-31 | $-0.06B | $0.14B | -37.82% |
| 2022-12-31 | $-0.06B | $0.15B | -35.60% |
| 2022-09-30 | $-0.06B | $0.16B | -33.05% |
| 2022-06-30 | $-0.05B | $0.17B | -29.15% |
| 2022-03-31 | $-0.05B | $0.18B | -26.74% |
| 2021-12-31 | $-0.05B | $0.19B | -24.14% |
| 2021-09-30 | $-0.05B | $0.20B | -21.33% |
| 2021-06-30 | $-0.04B | $0.21B | -35.94% |
| 2021-03-31 | $-0.04B | $0.21B | -66.96% |
| 2020-12-31 | $-0.03B | $0.22B | -984.62% |
| 2020-06-30 | $-0.02B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $0.354B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||